Anti-HLADQ1 [TAL 4.1]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
![Image thumbnail for Anti-HLADQ1 [TAL 4.1]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/47de4369-eb01-4d01-af49-58c58594cc9c.jpg)
| Catalogue Number | 151228 |
| Applications | ELISA FACS IHC WB |
| Antigen/Gene or Protein Targets | Human Leukocyte Antigen DQ1 (includes DQ5 and 6 ) |
| Reactivity | Human |
| Relevance | Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). TAL 4.1 can be used for tissue typing and detection of class II products. |
| Host | Mouse |
| Immunogen | Whole cells from the B line WT46 |
| Subclass | IgG2b |
| Molecular Weight (kDa) | 28 |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | RPMI 1640 + 10% FCS |
| Research Area | Immunology |
References: 2 entries
Kanangat et al. 2018. Hum Immunol. 79(7):558-563. PMID: 29656111.
WB
Bodmer et al. 1984. Br Med Bull. 40(3):267-75. PMID: 6205714.
Add a reference
References: 2 entries
Kanangat et al. 2018. Hum Immunol. 79(7):558-563. PMID: 29656111.
WB
Bodmer et al. 1984. Br Med Bull. 40(3):267-75. PMID: 6205714.
Add a reference
